FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Clinical trial NCT07540988 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07540988
- Sponsor
- Boehringer Ingelheim
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-28
- Primary completion
- 2028-12-05
- Enrollment
- 466
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.